Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
Nirav Dhanesha, Assistant Professor at the Louisiana State University, shared on LinkedIn:
”Latest publication from our lab in Blood Advance, Blood Journals Portfolio
Beyond its common application as a lineage marker to identify monocytes in flow-cytometry assays, CD14 is highly expressed in neutrophils and serves as a functional driver of DVT.
In this study, we identifies neutrophil CD14 as a specific driver and therapeutic target for DVT.
CoreFindings:
Identification: Multiomic profiling (RNA-seq, proteomics, flow cytometry) reveals neutrophil CD14 overexpression within 3-hr of DVT onset.
Mechanism: Elevated plasma G-CSF drives this CD14 expression via the transcription factor C/EBPα.
InVivo Validation: Neutrophil-specific CD14 knockdown significantly reduces DVT severity.
Translational Relevance: In G-CSF-stimulated primary human neutrophils, CD14 inhibition reduces inflammation and NETosis.
These data establish the G-CSF/C/EBPα/CD14 axis as a primary mechanism in DVT pathogenesis and suggest CD14 as a viable site for therapeutic intervention.
Link of the paper.
Congratulations to the first authors, Nilesh Pandey and Harpreet Kaur, Ph.D., for their hard work and persistence.
Many thanks to all the collaborators and co-authors for their contributions to this work.”
Article: Neutrophil CD14 is a Driver and a Therapeutic Target for Deep Vein Thrombosis
Authors: Nilesh Pandey, Harpreet Kaur, Raktim Mitra, Lakshmi Chandaluri, Nirvana Shaaban, Alexa Martinez, Evan Kidder, Sumit Kumar Anand, Megan Butler, Xiaolu Zhang, Dweipayan Goswami, Louise Frausto, Dhananjay Kumar, Rajan Pandit, Sandeep Das, Sumati Rohilla, Suman Mohajan, Gurranna Male, Amdadul Huque, Amr R Salem, Tarek Magdy, David S Gross, Karen Y Stokes, A Wayne Orr, Sultan Tousif, Arif Yurdagul Jr, Oren Rom, Nirav Dhanesha
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 24, 2026, 07:13William Cadden: Risk–Benefit Considerations in Atrial Fibrillation
-
Apr 24, 2026, 06:58Zahra Ghasemi: The Human Reality of IVIG Access
-
Apr 24, 2026, 06:44Sandrine Meunier: Raising Awareness and Support for Hemophilia and Rare Bleeding Disorders
-
Apr 24, 2026, 06:25Octavio Marques Pontes-Neto: A Landmark Step in Stroke Prevention from The TRIDENT Trial Findings
-
Apr 24, 2026, 05:46Muhammad Alsabagh: Structured Clinical Algorithms for Pediatric and AYA Bone Marrow Failure Syndromes
-
Apr 23, 2026, 22:56Matt Simmonds: Having a Really Fabulous Time at the BSH 2026 Conference
-
Apr 23, 2026, 22:46Gloria Duah: Not All ‘O Negative’ Blood Is Safe for Every Patient
-
Apr 23, 2026, 22:46Luke McLaughlin: Is Haemophilia a Disability?
-
Apr 23, 2026, 22:44Sonia Wolf: On My Way Back From a Very Invigorating BSH